Hoppa till innehåll
/Ekonomisk utvärdering

Fast-track access to urologic care for patients with macroscopic haematuria is efficient and cost-effective: results from a prospective intervention study

Liedberg F, Gerdtham U, Gralén K, Gudjonsson S, Jahnson S, Johansson I, Hagberg O, Larsson S, Lind AK, Löfgren A, Wanegård J, Åberg H and Nilbert M

The delay between onset of macroscopic haematuria and diagnosis of bladder cancer is often long. In this studie we evaluated timely diagnosis and health-care costs for patients with macroscopic haematuria given fast-track access to diagnostics. Direct access to urologic expertise and fast-track diagnostics is motivated for patients with macroscopic haematuria to reduce diagnostic intervals and lower health-care expenditures.

British Journal of Cancer. 2016 Sep 27; 115(7): 770-5
DOI: 10.1038/bjc.2016.265